<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>31</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Delghingaro-Augusto, V.</AUTHOR>
		<AUTHOR>Nolan, C. J.</AUTHOR>
		<AUTHOR>Gupta, D.</AUTHOR>
		<AUTHOR>Jetton, T. L.</AUTHOR>
		<AUTHOR>Latour, M. G.</AUTHOR>
		<AUTHOR>Peshavaria, M.</AUTHOR>
		<AUTHOR>Madiraju, S. R.</AUTHOR>
		<AUTHOR>Joly, E.</AUTHOR>
		<AUTHOR>Peyot, M. L.</AUTHOR>
		<AUTHOR>Prentki, M.</AUTHOR>
		<AUTHOR>Leahy, J.</AUTHOR>
	</AUTHORS>
	<YEAR>2009</YEAR>
	<TITLE>Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass</TITLE>
	<SECONDARY_TITLE>Diabetologia</SECONDARY_TITLE>
	<VOLUME>52</VOLUME>
	<NUMBER>6</NUMBER>
	<PAGES>1122-32</PAGES>
	<DATE>Jun</DATE>
	<ISBN>1432-0428 (Electronic)</ISBN>
	<ACCESSION_NUMBER>19294363</ACCESSION_NUMBER>
	<KEYWORDS>
		<KEYWORD>Animals</KEYWORD>
		<KEYWORD>Body Weight</KEYWORD>
		<KEYWORD>Cell Proliferation</KEYWORD>
		<KEYWORD>Cells, Cultured</KEYWORD>
		<KEYWORD>Fatty Acids, Nonesterified/metabolism</KEYWORD>
		<KEYWORD>Hyperlipidemias/*metabolism/*pathology/physiopathology</KEYWORD>
		<KEYWORD>Immunohistochemistry</KEYWORD>
		<KEYWORD>Insulin/metabolism</KEYWORD>
		<KEYWORD>Insulin-Secreting Cells/cytology/metabolism/*pathology</KEYWORD>
		<KEYWORD>Islets of Langerhans/*pathology</KEYWORD>
		<KEYWORD>Lipid Metabolism/physiology</KEYWORD>
		<KEYWORD>Male</KEYWORD>
		<KEYWORD>Obesity/*metabolism/*pathology/physiopathology</KEYWORD>
		<KEYWORD>Pancreatectomy</KEYWORD>
		<KEYWORD>Proinsulin/metabolism</KEYWORD>
		<KEYWORD>Rats</KEYWORD>
		<KEYWORD>Rats, Zucker</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>AIMS/HYPOTHESIS: The Zucker fatty (ZF) rat subjected to 60% pancreatectomy (Px) develops moderate diabetes by 3 weeks. We determined whether a progressive fall in beta cell mass and/or beta cell dysfunction contribute to beta cell failure in this type 2 diabetes model. METHODS: Partial (60%) or sham Px was performed in ZF and Zucker lean (ZL) rats. At 3 weeks post-surgery, beta cell mass and proliferation, proinsulin biosynthesis, pancreatic insulin content, insulin secretion, and islet glucose and lipid metabolism were measured. RESULTS: ZL-Px rats maintained normal glycaemia and glucose-stimulated insulin secretion (GSIS) despite incomplete recovery of beta cell mass possibly due to compensatory enhanced islet glucose metabolism and lipolysis. ZF-Px rats developed moderate hyperglycaemia (14 mmol/l), hypertriacylglycerolaemia and relative hypoinsulinaemia. Despite beta cell mass recovery and normal arginine-induced insulin secretion, GSIS and pancreatic insulin content were profoundly lowered in ZF-Px rats. Proinsulin biosynthesis was not reduced. Compensatory increases in islet glucose metabolism above those observed in ZF-Sham rats were not seen in ZF-Px rats. Triacylglycerol content was not increased in ZF-Px islets, possibly due to lipodetoxification by enhanced lipolysis and fatty acid oxidation. Fatty acid accumulation into monoacylglycerol and diacylglycerol was increased in ZF-Px islets together with a 4.5-fold elevation in stearoyl-CoA desaturase mRNA expression. CONCLUSIONS/INTERPRETATION: Falling beta cell mass, reduced proinsulin biosynthesis and islet steatosis are not implicated in early beta cell failure and glucolipotoxicity in ZF-Px rats. Rather, severe beta cell dysfunction with a specific reduction in GSIS and marked depletion of beta cell insulin stores with altered lipid partitioning underlie beta cell failure in this animal model of type 2 diabetes.</ABSTRACT>
	<NOTES>418077/Medical Research Council/United KingdomDK56818/DK/NIDDK NIH HHS/United StatesDK59851/DK/NIDDK NIH HHS/United StatesDK66635/DK/NIDDK NIH HHS/United StatesJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tGermany</NOTES>
	<URL>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19294363</URL>
</RECORD>
</RECORDS></XML>
